Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm(3)

BACKGROUND: Antiretroviral therapy (ART) with a generic fixed-dose combination (FDC) of stavudine (d4T)/lamivudine (3TC)/nevirapine (NVP) is widely used in developing countries. The clinical data of this FDC among very advanced HIV-infected patients is limited. METHODS: A retrospective cohort study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Manosuthi, Weerawat, Chimsuntorn, Sukanya, Likanonsakul, Sirirat, Sungkanuparph, Somnuek
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2007
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1828738/
https://ncbi.nlm.nih.gov/pubmed/17352834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-4-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados